3164 — GenMont Biotech Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesBalancedMicro CapSucker Stock

Annual balance sheet for GenMont Biotech, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	526	465	422	401	328
Net Total Accounts Receivable
Net Total Receivables	72	46.4	55.1	51.8	40
Total Inventory
Prepaid Expenses
Total Current Assets	684	596	581	522	466
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	818	954	1,059	1,113	1,060
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,571	1,613	1,698	1,696	1,653
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	88.3	95	139	161	146
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	186	284	322	344	337
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	1,385	1,329	1,376	1,351	1,316
Total Liabilities & Shareholders' Equity	1,571	1,613	1,698	1,696	1,653
Total Common Shares Outstanding